Literature DB >> 31811879

Botulinum toxin: Pharmacology and injectable administration for the treatment of primary hyperhidrosis.

Shiri Nawrocki1, Jisun Cha2.   

Abstract

Hyperhidrosis is a dermatological condition defined by excessive sweating beyond thermoregulatory needs with significant effects on patients' quality of life. Hyperhidrosis is categorized as primary or secondary: primary hyperhidrosis is mostly focal and idiopathic, whereas secondary hyperhidrosis is commonly generalized and caused by an underlying medical condition or use of medications. Various surgical and nonsurgical therapies exist for primary hyperhidrosis. Although botulinum toxin is one of the deadliest toxins known, when used in small doses, it is one of the most effective therapies for primary hyperhidrosis. Botulinum toxin injections are widely used as a second-line primary hyperhidrosis treatment option once topical treatment strategies have failed. This article provides an overview of the commercially available botulinum toxin formulations and their applications in the treatment of primary hyperhidrosis.
Copyright © 2020 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clostridium bacteria; abobotulinumtoxinA; axillary hyperhidrosis; botulinum neurotoxin; botulinum toxin; craniofacial hyperhidrosis; excessive sweating; incobotulinumtoxinA; onabotulinumtoxinA; palmar hyperhidrosis; plantar hyperhidrosis; prabotulinumtoxinA; primary hyperhidrosis; rimabotulinumtoxinB

Year:  2019        PMID: 31811879     DOI: 10.1016/j.jaad.2019.11.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Botulinum Toxin Type A for Treatment of Forehead Hyperhidrosis: Multicenter Clinical Experience and Review from Literature.

Authors:  Anna Campanati; Emanuela Martina; Stamatis Gregoriou; George Kontochristopoulos; Matteo Paolinelli; Federico Diotallevi; Giulia Radi; Ivan Bobyr; Barbara Marconi; Giulio Gualdi; Paolo Amerio; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2022-05-27       Impact factor: 5.075

2.  Perianal Hyperhidrosis Successfully Treated with Botulinum Toxin A.

Authors:  Leandra Reguero Del Cura; Marta Drake Monfort; Adrian De Quintana Sancho; Marcos Antonio González López
Journal:  Skin Appendage Disord       Date:  2021-04-28

3.  Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.

Authors:  Emanuela Martina; Federico Diotallevi; Giulia Radi; Anna Campanati; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546

4.  Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Huan Qian; Fangjie Shao; Cameron Lenahan; Anwen Shao; Yingjun Li
Journal:  Front Psychiatry       Date:  2020-12-04       Impact factor: 4.157

5.  A Practical Approach to the Diagnosis and Treatment of Palmar Hyperhidrosis.

Authors:  Max J Solish; Iryna Savinova; Michael J Weinberg
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-03-07

6.  Autonomic Dysfunction and Management after Spinal Cord Injury: A Narrative Review.

Authors:  Austin M Henke; Zackery J Billington; David R Gater
Journal:  J Pers Med       Date:  2022-07-07

7.  Chinese expert consensus on the surgical treatment of primary palmar hyperhidrosis (2021 version).

Authors:  Yanguo Liu; Wenhan Weng; Yuanrong Tu; Jun Wang
Journal:  Chin Med J (Engl)       Date:  2022-06-05       Impact factor: 6.133

8.  Discrimination of the Activity of Low-Affinity Wild-Type and High-Affinity Mutant Recombinant BoNT/B by a SIMA Cell-Based Reporter Release Assay.

Authors:  Frank Neuschäfer-Rube; Andrea Pathe-Neuschäfer-Rube; Gerhard P Püschel
Journal:  Toxins (Basel)       Date:  2022-01-17       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.